| Country | Contacts |
|---|---|
| United Kingdom, Ireland | For questions and information please contact our UK based Medical Information team on: Direct Line: 08007830033 (Freephone UK) For AE related questions and information please email us at AstraZenecaUKMCDrugSafety@astrazeneca.com For Product Quality related information please email us at mipqc.uk@astrazeneca.com T: +90 538 861 45 38 |
| Switzerland/Liechtenstein | For questions and information please call our medical information hotline on: +41 (0) 41 725 77 77 and related to Medical Information querries please send an email to medicalinfo.ch@astrazeneca.com |
| Malaysia | If your email is regarding an adverse event, please self-report via https://contactazmedical.astrazeneca.com within 24 HOURS of awareness. For AE related questions and information please email us at ae.malaysia@astrazeneca.com For MIR related questions and information please email us at medinfo-malaysia@astrazeneca.com and https://contactazmedical.astrazeneca.com |
| Singapore | For AE related questions and information please email us at patientsafety.sg@astrazeneca.com For MIR related questions and information please email us at medinfo.sg@astrazeneca.com For Product Quality related information please email us at Productcomplaint.SG@astrazeneca.com |
| India | For questions and information please email us at patientsafety.india@astrazeneca.com For Medical information please email us at med.info3@astrazeneca.com , For Product Quality related information please email us at productqualitycomplaints.india@astrazeneca.com |
| Bahrain, Kuwait, Oman, Qatar, United Arab Emirates, Pakistan | For AE related questions and information please email us at patientsafety-azgulf@astrazeneca.com For Medical Information related questions please email us at gulf-medicalinfo@astrazeneca.com For Product Quality related questions and information please email us at GulfQuality@astrazeneca.com |
| Liberia, Malawi, South Africa | For Medical Information related questions and information please email us at medinfo-sa@astrazeneca.com For Product Quality related questions and information please email us at PatientSafetySouthAfrica@astrazeneca.com |
| Ethiopia, Ghana, Kenya, Lesotho, Mauritius, Mozambique, Namibia, Nigeria, Rwanda, Seychelles, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe | For Medical information related related information please email us at deptomedico@astrazeneca.com , For Product Quality related information please email us at ProductQualitySouthAfrica@astrazeneca.com |
| Angola, Botswana, Burkina Faso, Central African Republic | For Medical information information please email us at ssa.meamedinfo@astrazeneca.com , For Product Quality related information please email us at ProductQualitySouthAfrica@astrazeneca.com |
| Egypt | For AE related related information please email us at PatientSafetyegypt@astrazeneca.com , For Medical information related information please email us at medinfo-egypt@astrazeneca.com , For Product Quality related information please email us at EgyptComplaints@astrazeneca.com |
| Central America & Caribbean (CAMCAR) | In case you require additional information, support or have any question, please contact Pharmacovigilance from the Medical Department of AstraZeneca CAMCAR Costa Rica S.A.: |
| Georgia | For questions and information please contact our PS team in Georgia: For AE related information please email us at Georgia.PatientSafety@astrazeneca.com For medical information related questions send email to medinfo.georgia@astrazeneca.com For PQC related information please send email to PQC.Georgia@astrazeneca.com |
| Israel | For farther information, support or questions, please contact us- AstraZeneca Israel. For AE related information please email us at ae.isreal@astrazeneca.com, safety.isreal@astrazeneca.com For medical information related questions send email to medinfo-isreal@astrazeneca.com For PQC related information please send email to mipqc.isreal@astrazeneca.com |
| Malta, Ireland | For further information, support or questions, please contact AstraZeneca Malta: Direct Line: 016097100 (Freephone Ireland) Email: Medicalinformationireland@astrazeneca.com Adverse events: Patient-Safety-Ireland@astrazeneca.com Medical Information and Product Quality complaints: MedicalInformationireland@astrazeneca.com |
| Canada | For questions and information, please contact AstraZeneca Canada Medical Information: English: 1-800-668-6000 |
| Philippines | If you have any concerns or inquiries about AstraZeneca product: You may report/request via the CHAMPion Form: https://contactazmedical.astrazeneca.com/ Concerns or inquiries may pertain to (but not limited to): *Adverse events are sometimes known as side effects and are unwanted or unexpected events or reactions to a medicine or device. Any questions or clarifications send email to ae.philippines@astrazeneca.com *Medical Information enquiries are medical or scientific questions relating to our medicines and devices. Any questions or clarifications send email to medinfo.ph@astrazeneca.com *Product quality complaints relate to a physical issue with a medicine or a device and/or its packaging. Any questions or clarifications send email to productquality.ph@astrazeneca.com |
| France | For information or questions, please contact the French Medical Information Team on +33 1 41 29 40 00 and for MIR related questions send email to InformationMedicaleAZFrance@astrazeneca.com |
| Slovenia | For AE related questions and information please email us at ae.slovenia@astrazeneca.com For MIR related questions and information please email us at mipqc.slovenia@astrazeneca.com, kakovost@astrazeneca.com For Product Quality related information please email us at mipqc.slovenia@astrazeneca.com T: +386 1 513 56 00 |
© AstraZeneca. All rights reserved.